IC
RARE icon

IEQ Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

IEQ Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
106,026
+79,693
+303% +$1.98M 0.02% 610
2026
Q1 		$552K Buy
+26,333
New +$593K ﹤0.01% 1256
2024
Q4 		– Sell
-8,434
Closed -$469K – 1420
2024
Q3 		$469K Buy
+8,434
New +$430K 0.01% 778

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

IEQ Capital's RARE Position: Q2 2026 in Review

IEQ Capital increased its Ultragenyx Pharmaceutical (RARE) stake by 303% in Q2 2026, buying an estimated $1.98M and bringing the position to 106,026 shares worth $3.54M. The position accounts for 0.02% of the portfolio, ranked #610.

IEQ Capital first reported a position in RARE in Q3 2024 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • IEQ Capital held 106,026 shares of Ultragenyx Pharmaceutical worth $3.54M as of Q2 2026.
  • IEQ Capital bought 79,693 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $1.98M.
  • Ultragenyx Pharmaceutical made up 0.02% of IEQ Capital's portfolio in Q2 2026, its #610 holding.
  • IEQ Capital first reported a position in Ultragenyx Pharmaceutical in Q3 2024 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.